P. Gubbins

发表

Smartphone medication adherence apps: potential benefits to patients and providers.

Lindsey E. Dayer, S. Heldenbrand, Paul Anderson, 2013, Journal of the American Pharmacists Association : JAPhA.

Kenya - Country economic memorandum : from economic growth to jobs and shared prosperity

P. Gubbins, T. Farole, John Randa, 2016 .

The Influence of Influenza and Pneumococcal Vaccines on Community-Acquired Pneumonia (CAP) Outcomes Among Elderly Patients

P. Gubbins, Chenghui Li, 2015, Current Infectious Disease Reports.

Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care professionals and patients.

Bradley C Martin, Kristie B. Hadden, Lindsey E. Dayer, 2016, Journal of the American Pharmacists Association : JAPhA.

Introduction to Drug-Drug Interactions

P. Gubbins, K. Rodvold, M. Pai, 2018 .

Evaluation Study of California's High Priority Schools Grant Program: Final Report.

P. Gubbins, T. Parrish, Jenifer J. Harr, 2007 .

Drug–drug interactions of antifungal agents and implications for patient care

P. Gubbins, J. Amsden, 2005, Expert opinion on pharmacotherapy.

Grapefruit juice decreases the systemic availability of itraconazole capsules in healthy volunteers.

P. Gubbins, B. Gurley, S. Penzak, 1999, Therapeutic drug monitoring.

Influence of Grapefruit Juice on the Systemic Availability of Itraconazole Oral Solution in Healthy Adult Volunteers

D. K. Williams, P. Gubbins, B. Gurley, 2004, Pharmacotherapy.

Examining sex-related differences in enteric itraconazole metabolism in healthy adults using grapefruit juice

D. K. Williams, P. Gubbins, B. Gurley, 2008, European Journal of Clinical Pharmacology.

Academic Help-Seeking Behavior Among Student Pharmacists

P. Gubbins, N. Payakachat, D. Ragland, 2013, American Journal of Pharmaceutical Education.

Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions

P. Gubbins, K. Rodvold, M. Pai, 2018, Infectious Disease.

Steady-State Pharmacokinetics of Oral Voriconazole and Its Primary Metabolite, N-Oxide Voriconazole, Pre- and Post-Autologous Peripheral Stem Cell Transplantation

E. Anaissie, P. Gubbins, J. Amsden, 2013, Antimicrobial Agents and Chemotherapy.

Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses

G. Campbell, P. Gubbins, K. Olsen, 1996, Antimicrobial agents and chemotherapy.

Fungal Infections: The Role of Prophylactic and Empiric Antifungal Therapy in ICU Patients

P. Gubbins, 2001 .

Tick‐Borne Bacterial, Rickettsial, Spirochetal, and Protozoal Infectious Diseases in the United States: A Comprehensive Review

P. Gubbins, Scott Warmack, J. Amsden, 2005, Pharmacotherapy.

Pharmacist use of point-of-care testing to improve access to care

P. Gubbins, Lisa M. Cillessen, Heather Lyons-Burney, 2021 .

Why are so Many Children Stunted in the Philippines?

P. Gubbins, G. Demombynes, M. Capanzana, 2020 .

Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection?

E. Anaissie, P. Gubbins, S. McConnell, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Characterizing and Predicting Amphotericin B‐Associated Nephrotoxicity in Bone Marrow or Peripheral Blood Stem Cell Transplant Recipients

E. Anaissie, P. Gubbins, S. Penzak, 2002, Pharmacotherapy.

Are COVID-19 age-mortality curves for 2020 flatter in developing countries? Evidence from a cross-sectional observational study of population-level official death counts and excess deaths estimates

P. Gubbins, G. Demombynes, D. de Walque, 2022, BMJ Open.

Pharmacokinetics and Safety of Oral Posaconazole in Neutropenic Stem Cell Transplant Recipients

E. Anaissie, P. Gubbins, S. Penzak, 2006, Antimicrobial Agents and Chemotherapy.

Therapeutic drug monitoring of vancomycin in a morbidly obese patient.

P. Gubbins, K. Rodvold, S. Penzak, 1998, Therapeutic drug monitoring.

The Association between Cryptococcal Variety and Immunocompetent and Immunocompromised Hosts

P. Gubbins, R. Martin, R. Martin, 1998, Pharmacotherapy.

Are antimicrobial-impregnated catheters effective? Replace the water and grab your washcloth, because we have a baby to wash.

E. Anaissie, P. Gubbins, S. McConnell, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CHAPTER 7 – Antifungal therapy

E. Anaissie, P. Gubbins, 2009 .

Financing of global health: tracking development assistance for health from 1990 to 2007

Katherine Leach-Kemon, C. Murray, C. Michaud, 2009, The Lancet.

Public financing of health in developing countries: a cross-national systematic analysis

Chunling Lu, Matthew T. Schneider, Katherine Leach-Kemon, 2010, The Lancet.

Questionable susceptibility reporting in a multicenter trial

P. Gubbins, R. Bradsher, 1995, Antimicrobial agents and chemotherapy.

COVID-19 Age-Mortality Curves for 2020 are Flatter in Developing Countries using Both Official Death Counts and Excess Deaths

P. Gubbins, B. Urdinola, G. Demombynes, 2021, Policy Research Working Papers.

Frequency, pathogenicity and microbiologic outcome of non-Candida albicans candiduria

P. Gubbins, P. Schreckenberger, L. Danziger, 1994, European Journal of Clinical Microbiology and Infectious Diseases.

Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450

P. Gubbins, Paul O Gubbins, 2011, Expert opinion on drug metabolism & toxicology.

Clinically relevant drug interactions of current antifungal agents

S. Heldenbrand, P. Gubbins, Paul O. Gubbins, 2010, Mycoses.

Effect of Interleukin 6 on the Hepatic Metabolism of Itraconazole and Its Metabolite Hydroxyitraconazole Using Primary Human Hepatocytes

P. Gubbins, B. Gurley, S. Penzak, 2003, Pharmacology.

Rapid and sensitive high performance liquid chromatographic method for the determination of itraconazole and its hydroxy-metabolite in human serum.

P. Gubbins, B. Gurley, J. Bowman, 1998, Journal of pharmaceutical and biomedical analysis.

Population Mobility, Globalization, and Antimicrobial Drug Resistance

P. Gubbins, W. Baine, D. Macpherson, 2009, Emerging infectious diseases.

Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients

P. Gubbins, 2007, Current opinion in infectious diseases.

Candidal Urinary Tract Infections: A Comprehensive Review of Their Diagnosis and Management

P. Gubbins, S. Piscitelli, L. Danziger, 1993, Pharmacotherapy.

Blastomycosis in children.

P. Gubbins, T. Darville, R. Jacobs, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Drug Absorption in Gastrointestinal Disease and Surgery

P. Gubbins, K. Bertch, 1991, Clinical pharmacokinetics.

Drug Absorption in Gastrointestinal Disease and Surgery

P. Gubbins, K. Bertch, 1989, Pharmacotherapy.

Antifungal Prophylaxis to Prevent Invasive Mycoses Among Bone Marrow Transplantation Recipients

P. Gubbins, S. Penzak, J. Bowman, 1998, Pharmacotherapy.

Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions

P. Gubbins, K. Rodvold, M. Pai, 2018, Infectious Disease.

Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis.

P. Gubbins, L. Wheat, M. Durkin, 2011, Diagnostic microbiology and infectious disease.

Steady state pharmacokinetics of oral voriconazole and its primary metabolite

P. Gubbins, J. Amsden, S. McConnell, 2013 .

Liposomal Amphotericin B: A Review of its use in the Treatment of Invasive Fungal Infections

P. Gubbins, T. Warmack, 2010 .

Surveillance of Treated and Untreated Funguria in a University Hospital

P. Gubbins, L. Danziger, D. Occhipinti, 1994, Pharmacotherapy.

Renal Interaction Between Itraconazole and Cimetidine

P. Gubbins, T. Dowling, C. Karyekar, 2004, Journal of clinical pharmacology.

Antifungal therapy.

E. Anaissie, P. Gubbins, 2020, Postgraduate medical journal.

APPE Evaluations are Positively Associated with MMI, Pre-pharmacy GPA and Pharmacy GPA

S. Heldenbrand, P. Gubbins, B. Martin, 2017, American Journal of Pharmaceutical Education.

Evaluation of P‐glycoprotein—Mediated Renal Drug Interactions in an MDR1‐MDCK Model

P. Gubbins, T. Garimella, T. Dowling, 2003, Pharmacotherapy.

Development, implementation and perceived benefits of student pharmacist learning experiences in transitions of care.

P. Gubbins, Elizabeth F. Englin, Heather Taylor, 2019, Currents in pharmacy teaching & learning.

The Need for PGY2‐Trained Clinical Pharmacy Specialists

John E. Murphy, P. Gubbins, K. Ragucci, 2014, Pharmacotherapy.

The Need for PGY 2-Trained Clinical Pharmacy Specialists American College of Clinical Pharmacy

John E. Murphy, P. Gubbins, K. Ragucci, 2014 .

Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy.

E. Anaissie, P. Gubbins, S. Penzak, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Family Commitment and Work Characteristics among Pharmacists

Ashley N. Castleberry, P. Gubbins, N. Payakachat, 2015, Pharmacy.

Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.

M. Klepser, Allison M. Dering-Anderson, P. Gubbins, 2014, Journal of the American Pharmacists Association : JAPhA.

A critical appraisal of the membrane filter technic.

P. Gubbins, G. B. Morgan, V. Morgan, 1965, Health laboratory science.

From the editor

D. Klepser, M. Klepser, Allison M. Dering-Anderson, 2014, American journal of pharmaceutical education.

Potential Benefits to Patients and Providers

S. Heldenbrand, Paul Anderson, P. Gubbins, 2013 .

Kenya economic update : time to shift gears - accelerating growth and poverty reduction in the new Kenya

P. Gubbins, John Randa, 2013 .

Developing a comprehensive time series of GDP per capita for 210 countries from 1950 to 2015

C. Murray, E. Gakidou, S. James, 2012, Population Health Metrics.

Pharmacists’ role in infectious pandemics: illustration with COVID-19

P. Gubbins, Lisa M. Cillessen, Heather Lyons-Burney, 2020, Remington.

Developing and Sustaining a Culture of Scholarship

P. Gubbins, M. Luer, I. Reddy, 2003 .

Exploration of Methods Used by Pharmacy Professional Programs to Contract with Experiential Practice Sites

P. Gubbins, L. Garavalia, V. Ruehter, 2016, American Journal of Pharmaceutical Education.

Successful California Schools in the Context of Educational Adequacy.

P. Gubbins, Priyanka Anand, T. Parrish, 2007 .

Self-assessed proficiency and application of various skills learned during postgraduate pharmacy teaching skills development programs

J. Gervasio, P. Gubbins, A. Ratka, 2010 .

The S cholarship of Teaching and Learning: An Opportunity for Clinical Faculty Members in Academic Pharmacy and Other Health Professions to Develop a Program of Scholarship

P. Gubbins, 2014 .

Potential for Pharmacy–Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases

M. Klepser, P. Gubbins, A. Adams, 2017, Journal of public health management and practice : JPHMP.

Multiple Mini-Interview Performance Predicts Academic Difficulty in the PharmD Curriculum

Cindy D Stowe, Bradley C Martin, S. Heldenbrand, 2016, American Journal of Pharmaceutical Education.

Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy

P. Gubbins, J. Amsden, 2017, Expert opinion on drug metabolism & toxicology.

Challenges and Opportunities of Mobile Phone-Based Data Collection: Evidence from South Sudan

Gabriel Demombynes, Paul Gubbins, Alessandro Romeo, 2013 .

Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points

Bradley C Martin, Kristie B. Hadden, S. Heldenbrand, 2017, JMIR mHealth and uHealth.

Rapid and sensitive high-performance liquid chromatographic method for the determination of ritonavir in human plasma.

P. Gubbins, S. Penzak, W. D. Lawhorn, 2001, International journal of clinical pharmacology and therapeutics.

Prior pneumococcal and influenza vaccinations and in-hospital outcomes for community-acquired pneumonia in elderly veterans.

P. Gubbins, Chenghui Li, Guoqing J. Chen, 2015, Journal of hospital medicine.

Exploring strategies to increase college students' motivation to receive their annual influenza vaccine.

P. Gubbins, Lisa M. Cillessen, Kelsey R Habighorst, 2022, Journal of American College Health.

Evaluation Study of the Immediate Intervention/Underperforming Schools Program of the Public Schools Accountability Act of 1999. Final Report.

P. Gubbins, Priyanka Anand, T. Parrish, 2005 .

Innovation in Clinical Pharmacy Practice and Opportunities for Academic–Practice Partnership

Jason C. Gallagher, Samuel G. Johnson, P. Gubbins, 2014, Pharmacotherapy.

Investigation of an Outbreak of Gram-Negative Bacteremia Among Hematology-Oncology Outpatients

E. Anaissie, P. Gubbins, S. Penzak, 2000, Infection Control & Hospital Epidemiology.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

J. S. Daly, A. Casadevall, I. Sia, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sceptical optimism: a new take on global health data

Matthew T. Schneider, Kyle Foreman, N. Fullman, 2009, The Lancet.

Developing and Sustaining a Culture of Scholarship

P. Gubbins, M. Luer, I. Reddy, 2003, American Journal of Pharmaceutical Education.

SPECIAL ARTICLES Developing and Sustaining a Culture of Scholarship

P. Gubbins, M. Luer, I. Reddy, 2003 .

Benchmarking in Academic Pharmacy Departments

P. Gubbins, M. Chisholm-Burns, J. Bosso, 2010, American Journal of Pharmaceutical Education.

SPECIAL ARTICLES Benchmarking in Academic Pharmacy Departments

P. Gubbins, J. Bosso, J. Nappi, 2010 .